About Drug Hunter
Drug Hunter is a private company based in Portland, Oregon, incorporated in 2022 in Delaware. It has reported $6,791,763 raised in three offerings on Form D since January 2022. Its chief executive is Dennis Hu.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 5, 2025 | Sep 19, 2025 | $6,043,381of $7.0M target | 13 | $464K | EquityRule 506(b) | Form D ↗ |
| Mar 15, 2024 | Mar 15, 2024 | $50,000of $2.0M target | 1 | $50,000 | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 7, 2022 | Jan 13, 2022amended Jan 9, 2023 | $698,382of $1.5M target | 9 | $77,598 | Equity, Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $6,791,763 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Drug Hunter's Form D filed Sep 19, 2025.
DH
Dennis Hu
Chief Executive Officer and director
TL
Thomas Lehrman
Director
Also a director at Istari Digital and an executive officer at Teamworthy Ventures.